Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fiduciary Trust Co. decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,480 shares of the biopharmaceutical company’s stock after selling 29 shares during the quarter. Fiduciary Trust Co.’s […]
Cutter & CO Brokerage Inc. lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.2% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 8,121 shares of the biopharmaceutical company’s stock after selling 20 shares during the quarter. Regeneron Pharmaceuticals comprises about 1.7% of Cutter & CO Brokerage Inc.’s investment portfolio, […]
Daiwa Securities Group Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,680 shares of the biopharmaceutical company’s stock after buying an additional 21 shares […]
Event-free survival of investigational use of Libtayo® (cemiplimab) in neoadjuvant cutaneous squamous cell carcinoma (CSCC) from Phase 2 trial to be...
AlphaMark Advisors LLC cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 1,891 shares of the biopharmaceutical company’s stock after selling 424 shares during the quarter. AlphaMark Advisors LLC’s holdings in Regeneron Pharmaceuticals were worth $1,359,000 at the end of […]